vTitan Corporation, a MedTech company focused on innovative healthcare technologies, has introduced vCardio, a single-lead wearable cardiac monitor designed for point-of-care use. The device is fully developed and manufactured in India, positioning vTitan among the first companies in the country to provide an end-to-end solution from hardware to cloud-based AI analytics in the health-tech sector.
Health Technology Insights: Ardent Health Announces $50 Million Share Repurchase Program Authorization
vCardio has been engineered to offer continuous smart monitoring for early detection of cardiac events and for vigilant post-surgical care. With this new launch, vTitan aims to make point-of-care cardiac services more accessible to both patients and clinics.
“The cardiac monitoring market currently faces a significant gap,” said Prasad Maganti, CEO of vTitan. “There is a strong need for point-of-care cardiac screening at outpatient clinics, continuous monitoring in pre- and post-surgical environments, and extended home monitoring for patients at risk of cardiac events. We built vCardio, an edge-AI-enabled cardiac monitor, from the ground up with clinical workflows in mind. Our goal was to address this market need and make cardiac care safer, more intelligent, and widely accessible.”
Health Technology Insights: PCI Pal Launches Secure Payment Solution for Healthcare Sector
The device is compact and lightweight, specifically designed for remote patient monitoring in homecare, geriatric care, and clinical environments. With Bluetooth connectivity, vCardio seamlessly integrates with the vCardio mobile app and software platform. Its comfortable design allows patients to wear it for long periods, enabling continuous monitoring throughout recovery.
vCardio simplifies patient registration and device activation, ensuring continuous ECG capture and real-time analysis. The system can detect abnormalities and alert clinicians immediately. In clinical settings, the device can provide a 5-10 minute recording with on-device edge-AI processing, while for 7-10 day home monitoring, data is securely uploaded to the cloud for in-depth analysis. The platform generates event-based snapshots along with hourly and daily summaries for physician review. Hospitals and clinics can also manage patient records efficiently while monitoring patients remotely.
The device’s AI algorithms can detect and classify more than 20 clinically significant cardiac arrhythmias in real-time and through post-recording analysis over the monitoring period. Clinically validated and capable of beat-to-beat analysis, vCardio equips healthcare professionals with faster and more precise rhythm insights. This enhances diagnostic confidence, streamlines workflows, and improves patient outcomes.
In rural regions, where access to specialists is limited, vCardio plays an important role in healthcare delivery. By analyzing baseline data and identifying potential cardiac issues, the device supports early prevention and mitigation strategies. It provides a vital solution for outpatient services in underserved areas, ensuring patients receive timely care.
“By combining patient-friendly design with advanced remote monitoring, we are working to transform how cardiac care is delivered,” Maganti added. “Our platform allows healthcare systems to extend clinical-grade cardiac surveillance beyond hospital walls, improving outcomes and lowering the complexity and cost of care coordination regardless of where patients are located.”
Founded in 2010, vTitan offers a broad portfolio of med-tech solutions spanning infusion, radiology, urology, monitoring, and cardiology. All products are designed, developed, and manufactured in-house. The company remains committed to advancing technology that enhances clinical efficiency and supports better patient outcomes.
Health Technology Insights: Health Technology Insights: Latest News And Innovations – Roundup 18 November 2025
To participate in our interviews, please write to our HealthTech Media Room at info@intentamplify.com
